Biotech Catalyst Calendar
Upcoming FDA decisions, advisory committees, EMA CHMP opinions, clinical-trial readouts and earnings for the next 14 days. Every date links to its primary source. Updated daily from official registries.
Month pages: PDUFA August 2026 · CHMP August 2026 · What do these events mean?
Friday, August 28, 2026
- CT ACRS Aclaris Therapeutics, Inc. Trial Readout: PHASE2 - Atopic Dermatitis, Atopic 2026-08-28
- CT BMRN BioMarin Pharmaceutical Inc. Trial Readout: PHASE4 - Phenylketonuria, PKU 2026-08-28
- CT DFTX Definium Therapeutics, Inc. Trial Readout: PHASE3 - Generalized Anxiety Disorder 2026-08-28
- CT EWTX Edgewise Therapeutics, Inc. Trial Readout: N/A - Becker Muscular Dystrophy, Muscular Dystrophies 2026-08-28
- Trial readout GILD Gilead Sciences, Inc. Trial Readout: PHASE3 - Disseminated Histoplasma Capsulatum Infection, AIDS and Infections 2026-08-28
- CT GPCR Structure Therapeutics Inc. Trial Readout: PHASE2 - Obesity, Overweight, or Chronic Weight Management 2026-08-28
- CT IMVT Immunovant, Inc. Trial Readout: PHASE3 - Thyroid Eye Disease 2026-08-28
- CT KPTI Karyopharm Therapeutics Inc. Trial Readout: PHASE3 - Endometrial Cancer 2026-08-28
- CT KURA Kura Oncology, Inc. Trial Readout: PHASE1 - AML, AML With Mutated NPM1 2026-08-28
- CT KYTX Kyverna Therapeutics, Inc. Trial Readout: PHASE1, PHASE2 - Lupus Nephritis, Lupus Nephritis - World Health Organization (WHO) Class III 2026-08-28
- CT MIRM Mirum Pharmaceuticals, Inc. Trial Readout: PHASE3 - Chronic Hepatitis D Infection 2026-08-28
- CT MPLT MapLight Therapeutics, Inc. Trial Readout: PHASE2 - Schizophrenia 2026-08-28
- CT MYGN Myriad Genetics, Inc. Trial Readout: PHASE1 - Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation 2026-08-28
- Trial readout NTRA Natera, Inc. Trial Readout: N/A - Lung Transplant Rejection 2026-08-28
- CT PEPG PepGen Inc. Trial Readout: PHASE2 - Myotonic Dystrophy 1 2026-08-28
- Trial readout RGNX REGENXBIO Inc. Trial Readout: PHASE2, PHASE3 - Duchenne Muscular Dystrophy 2026-08-28
- CT RIGL Rigel Pharmaceuticals, Inc. Trial Readout: PHASE1, PHASE2 - Low Risk Myelodysplastic Syndromes 2026-08-28
- CT XENE Xenon Pharmaceuticals Inc. Trial Readout: PHASE3 - Major Depressive Disorder 2026-08-28
- + 42 earnings reports this day — see the interactive calendar
Sunday, August 30, 2026
Monday, August 31, 2026
- Trial readout DXCM DexCom, Inc. Trial Readout: NA - Type-1-Diabetes 2026-08-31
- Trial readout EXEL Exelixis, Inc. Trial Readout: PHASE1 - Neoplasm Malignant, Renal Cell Carcinoma 2026-08-31
- CT NOVO-B.CO Novo Nordisk A/S Trial Readout: N/A - Type 2 Diabetes 2026-08-31
- CT NRIX Nurix Therapeutics, Inc. Trial Readout: PHASE1 - Ovarian Cancer, Epithelial, Gastric Cancer 2026-08-31
- CT SGHT Sight Sciences, Inc. Trial Readout: NA - Primary Open Angle Glaucoma 2026-08-31
- CT VRTX Vertex Pharmaceuticals Incorporated Trial Readout: N/A - Cystic Fibrosis 2026-08-31
- + 15 earnings reports this day — see the interactive calendar
Tuesday, September 1, 2026
Saturday, September 5, 2026
Thursday, September 10, 2026
- CT SNY Sanofi Trial Readout: N/A - Fabry Disease 2026-09-10
- + 24 earnings reports this day — see the interactive calendar
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.